I
INSD
vs
S&P 500
S&P 500
Over the past 12 months, INSD has underperformed S&P 500, delivering a return of -91% compared to the S&P 500's +14% growth.
Stocks Performance
INSD vs S&P 500
Performance Gap
INSD vs S&P 500
Performance By Year
INSD vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Instadose Pharma Corp
Glance View
Instadose Pharma Corp. engages in the designing, manufacturing and selling of micro-furniture that transforms any small space, particularly apartments and condominiums into functional spaces. The company is headquartered in Chesapeake, Virginia. The company went IPO on 2019-03-07. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canada’s Global Distribution Platform spans five (5) continent, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include Organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation Participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies; and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents. Its subsidiaries include Instadose Pharma, LDA and Instadose Pharma, LDA.
